ARCHIVES

Includes May Business & Regulatory Report (8-page issue).

This article is from The Cancer Letter archive.

Vol. 29 No. 23 | June 6, 2003

Download PDF Visit The Full Archive

Related Articles

Calcitrol+Docetaxel Prolongs Survival In Prostate Cancer

June 24, 2005

Generic Drug Makers Set Sights In Taxol Worldwide Market

April 2, 1993

In Brief: Cancer Panel To Meet Aug.29; RFP On Impact Of Planning Cancelled As Being “Premature“

August 15, 1980

Rosenberg’s Latest Results: 22% Response Seen With LAK/IL-2, 13% With High Dose IL-2 Alone

April 10, 1987

In Brief: Hawaii Center Searching For New Director: Rosenberg Denies Report He’s Going To Tampa

June 7, 1985

GSK’s Votrient Approved For Advanced Kidney Cancer

October 30, 2009